Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Search results are limited to:
Abstract Book of the 7th European Myeloma Network Meeting, Prague, 16-18 April 2026
Vol. 111 No. s2
Advanced filters
Search the full archive

P33 | ARLOCABTAGENE AUTOLEUCEL, A GPRC5D-TARGETED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1 SAFETY AND EFFICACY RESULTS IN PATIENTS WITH 1–3 PRIOR REGIMENS (1012 Online Views)

S. Bal1, M. Htut2, J. Berdeja3, L. Anderson4, A. Rossi5, T. Gregory6, L. Costa1, H. Hu7, Z. Guo7, J. Chen7, K. Jordahl7, N. Sarkis7, S. Ziyad7, W.M. Kao7, A. Kaeding7, M. Burgess7, O. Nadeem8

1 University of Alabama at Birmingham, USA
2 City of Hope Comprehensive Cancer Center, Duarte, USA
3 Greco-Hainsworth Tennessee Oncology Center for Research, Nashville, USA
4 Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, USA
5 Icahn School of Medicine at Mount Sinai, New York, USA
6 Colorado Blood Cancer Institute, Sarah Cannon Cancer Network, Denver, USA
7 Bristol Myers Squibb, Princeton, USA
8 Dana-Farber Cancer Institute, Boston, USA
RRMM CAR-T cells BCMA
1 - 1 of 1 items
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online